The tumor suppressor function of miR-17-92a cluster in prostate cancer cells is supported by our results showing reduced cell proliferation and reduced phosphorylation/activation of ERK1/2 kinases and AKT in these cells. Here, MAPK3 is linked to prostate carcinoma.